Becoming a Unicorn: GenePlanet’s Strategic Investment from Lauxera Propels Slovenia’s Growth

GenePlanet, a company based in Ljubljana, specializes in genomics and laboratory services, offering advanced genetic testing and next-generation sequencing (NGS) solutions on a global scale. Recently, they have received a significant investment from Lauxera Capital Partners, a renowned HealthTech investor.

As a result of this investment, BlackPeak Capital, an existing investor in GenePlanet, has partially divested its stake in the company while still maintaining a substantial ownership interest. Niklas Pichler, Managing Partner at BlackPeak Capital, expressed his confidence in GenePlanet’s growth potential and the success of their international expansion efforts.

Founded by Marko Bitenc in 2008, GenePlanet offers a wide range of genomic solutions for clinical, research, and preventive purposes, along with comprehensive NGS services for healthcare and research partners worldwide.

Over the years, GenePlanet has significantly expanded its global presence, operating in more than 50 markets across various continents. They have also completed strategic acquisitions to enhance their technology, geographic reach, and talent pool.

In a recent development, GenePlanet acquired New Era Genetics, a genetic testing company in Hungary, further strengthening its position in the market. The company’s laboratory in Zagreb serves as a central hub, supported by additional facilities in Sweden and Hungary.

With the backing of Lauxera Capital Partners, GenePlanet aims to expand its genetic testing product portfolio, particularly in oncology and rare diseases, and target new markets in Western Europe and the United States.

Victor Decrion, Managing Partner at Lauxera Capital Partners, emphasized the importance of companies like GenePlanet in advancing genomic-based personalized medicine in Europe. The company plans to utilize the investment to drive organic growth, expand geographically, and pursue further acquisitions.

In conclusion, GenePlanet is poised for continued success with a focus on innovation, expansion, and delivering cutting-edge genetic solutions to a global audience. The collaboration with Lauxera Capital Partners signifies a new chapter in the company’s journey towards becoming a leader in the genomics industry.